BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10099901)

  • 1. The ultimate follow-up.
    Coats AJ
    Eur Heart J; 1999 Jan; 20(2):85-6. PubMed ID: 10099901
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Singh regarding article, "Enalapril in infants with single ventricle: results of a multicenter randomized trial".
    Singh TP
    Circulation; 2011 Mar; 123(10):e374. PubMed ID: 21403120
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
    MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
    [No Abstract]   [Full Text] [Related]  

  • 4. [Risk reduction of acute heart failure with initial administration of beta-blockers].
    Med Monatsschr Pharm; 2007 Apr; 30(4):158. PubMed ID: 17484449
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter by Burchill et al regarding article, "Enalapril in infants with single ventricle: results of a multicenter randomized trial".
    Burchill LJ; Ross HJ; Wald RM
    Circulation; 2011 Mar; 123(10):e373. PubMed ID: 21403119
    [No Abstract]   [Full Text] [Related]  

  • 6. Using Cardicor as first-line therapy in heart failure : CiBis iii.
    Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimizing the use of ACE inhibitors in patients with congestive heart failure.
    Tsikouris JP
    Conn Med; 1999 Feb; 63(2):91-3. PubMed ID: 10188339
    [No Abstract]   [Full Text] [Related]  

  • 8. Pleiotropic effects of angiotensin-converting enzyme inhibitors and the future of cachexia therapy.
    von Haehling S; Sandek A; Anker SD
    J Am Geriatr Soc; 2005 Nov; 53(11):2030-1. PubMed ID: 16274392
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
    Modesti PA; Vanni S; Gensini GF
    Ital Heart J Suppl; 2003 Aug; 4(8):623-34. PubMed ID: 14655458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ednit in the treatment of congestive heart failure in chronic obstructive bronchitis].
    Shkol'nik MA; Sheĭkh AT; Butorov IV; Duduleĭ RF
    Klin Med (Mosk); 2000; 78(7):56-8. PubMed ID: 10979645
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of enap and oliphen combined treatment of chronic pulmonary hypertension].
    Shkol'nik MA; Butorov IV; Fuduleĭ RF; Paraska VI; Bodrug NI
    Klin Med (Mosk); 1999; 77(6):26-7. PubMed ID: 10459215
    [No Abstract]   [Full Text] [Related]  

  • 14. Heart failure.
    McKelvie R
    Clin Evid; 2002 Jun; (7):57-78. PubMed ID: 12230638
    [No Abstract]   [Full Text] [Related]  

  • 15. Renpress, Sandopril (Spirapril/TI 211-950). Summary of chemical, pharmacological and clinical properties.
    Jerie P; Kremer HJ
    Cor Vasa; 1992; 34(1):82-7. PubMed ID: 1288944
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved outcome in heart failure.
    Armstrong PW
    Int J Clin Pract Suppl; 1999 Apr; 100():10-1. PubMed ID: 10658291
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [X-SOLVD].
    Kubota T
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():516-20. PubMed ID: 17511102
    [No Abstract]   [Full Text] [Related]  

  • 19. Enalapril and QTC dispersion in congestive heart failure.
    Brockmeier LB
    Am J Cardiol; 1997 Dec; 80(12):1643. PubMed ID: 9416960
    [No Abstract]   [Full Text] [Related]  

  • 20. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
    Vermes E; Tardif JC; Bourassa MG; Racine N; Levesque S; White M; Guerra PG; Ducharme A
    Circulation; 2003 Jun; 107(23):2926-31. PubMed ID: 12771010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.